Parliamentary Search

Written question asked by Baroness Featherstone (Liberal Democrat) on Thursday, 26 March 2026, in the House of Lords. It was due for an answer on Monday, 13 April 2026. It was answered by Baroness Anderson of Stoke-on-Trent (Labour) on Thursday, 9 April 2026 on behalf of the Cabinet Office.

Blood: Contamination

Question

To ask His Majesty's Government what consideration they have given to introducing a tax on companies which benefited from (1) the research conducted on British infected blood victims, and (2) the drugs used to treat infected blood patients; and what assessment they have made of the benefits and risks of taxing those companies.

Answer

The Infected Blood Inquiry recommended that a compensation scheme be set up as soon as possible, and by centrally funding the scheme, the Government has been able quickly allocate the money necessary.

The Government firmly believes that access to redress is fundamental in upholding justice and fairness in our society. People must have avenues to seek recourse when they have been wronged or harmed. We hope the Infected Blood Compensation Scheme provides some closure to those who have been wronged under some of those most devastating circumstances.

Secondary information

Type
Written question
Reference
HL16067
Session
2024-26
Subjects
Contamination Blood Drugs Research Taxation
Link
View this Written question on www.parliament.uk